Bessho et al. found that TB403, a monoclonal antibody against PGF, could inhibit the VEGF pathway to regulate angiogenesis escape in ccRCC, suggesting that PGF might contribute to the development of ccRCC [47]. The gene discussed is VEGFA; the disease is nonpapillary renal cell carcinoma.